Page 115 - 201901
P. 115
第 36 卷第 1 期 精 细 化 工 Vol.36, No.1
201 9 年 1 月 FINE CHEMICALS Jan. 2019
医药与日化原料
RDEA3170 合成工艺优化
*
胡 旭,尹传奇 ,杨梦然,傅 晶,吴 莉,冯权武
(武汉工程大学 化学与环境工程学院,湖北 武汉 430205)
摘要:以 1,4-二溴萘为起始原料,经溴-镁交换、羧基化、酰胺化和脱水反应,优化了 4-溴-1-萘甲腈(Ⅳ)合成
方法。通过连续反应法,以 Pd(PPh 3 ) 2 Cl 2 催化实现了 4-溴-1-萘甲腈的 Miyaura 硼烷基化及其产物(4-氰基萘-1-基)
硼酸频那醇酯(Ⅴ)与 2-((3-溴吡啶-4-基)硫)-2-甲基丙酸乙酯(Ⅰ)的 Suzuki 偶联,得到 2-((3-(4-氰基萘-1-基)吡
啶-4-基)硫)-2-甲基丙酸乙酯(Ⅵ)。连续反应的最佳工艺条件为:n(联硼酸频那醇酯)∶n(Ⅳ)∶n(Ⅰ)∶n
〔Pd(PPh 3 ) 2 Cl 2 〕∶n(KOAc)∶n(K 2 CO 3 )=1.1∶1∶1∶0.06∶3∶3;KOAc 和 K 2 CO 3 分别作为 Miyaura 硼烷基化和
Suzuki 偶联反应的碱依次加入,相应的反应温度分别为 80 和 110 ℃,反应时间分别为 2 和 12 h。化合物Ⅵ水解
1
13
得到产品 RDEA3170〔2-((3-(4-氰基萘-1-基)吡啶-4-基)硫)-2-甲基丙酸〕,其结构经 HNMR 和 CNMR 表征。该
合成工艺 RDEA3170 的总收率达到 42%,适合工业化生产。
关键词:4-溴-1-萘甲腈;溴-镁交换反应;连续反应法;Suzuki 偶联;RDEA3170;合成工艺优化;医药原料
中图分类号:TQ460.31 文献标识码:A 文章编号:1003-5214 (2019) 01-0101-05
Synthetic Process Optimization of RDEA3170
*
HU Xu, YIN Chuan-qi , YANG Meng-ran, FU Jing, WU Li, FENG Quan-wu
(School of Chemistry and Environmental Engineering, Wuhan Institute of Technology, Wuhan 430205, Hubei, China)
Abstract: A new method for the synthesis of 4-bromo-1-naphthonitrile (Ⅳ) from 1,4-dibromonaphthalene
was conducted by bromo-magnesium exchange reaction, carboxylation, amidation and dehydration. In the
presence of catalyst Pd(PPh 3) 2Cl 2, the Miyaura borylation reaction enabled the synthesis of 4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthonitrile (Ⅴ) by cross-coupling of bis (pinacolato) diboron
(BPIN) 2 with 4-bromo-1-naphthonitrile and the Suzuki coupling reaction between intermediate Ⅴ with
ethyl 2-(3-bromopyridin-4-ylthio)-2-methylpropanoate (Ⅰ) led to ethyl 2-(3-(4-cyanonaphthalen-1-yl) pyridin-
4-ylthio)-2-methylpropanoate (Ⅵ) by continuous reaction process. The optimum conditions were as follows:
n[(BPIN) 2]∶n(Ⅳ)∶n(Ⅰ)∶n[Pd(PPh 3) 2Cl 2]∶n(KOAc)∶n(K 2CO 3)=1.1∶1∶1∶0.06∶3∶3, for the
Miyaura borylation, KOAc used as base, reaction temperature 80 ℃, reaction time 2 h, but for the Suzuki
coupling, K 2CO 3 used as base, reaction temperature 110 ℃, reaction time 12 h. The final product
RDEA3170 [2-(3-(4-cyanonaphthalen-1-yl)pyridin-2-ylthio)-2-methylpropanoic acid] was obtained by
1
13
hydrolysis of compound Ⅵ and characterized by H NMR and C NMR. The overall yield of RDEA3170
was up to 42%. This synthesis process is suitable for industrial production.
Key words: 4-bromo-1-naphthonitrile; bromo-magnesium exchange reaction; continuous reaction process;
Suzuki coupling; RDEA3170; synthetic process optimization; drug materials
Foundation items: Key Project of Hubei Provincial Department of Education (D20141510); Project of
Hubei Provincial Department of Education (B2017053)
[2]
[3]
RDEA3170,化学名称为 2-((3-(4-氰基萘-1-基) 比第一代抑制剂 Lesinurad 药效更强,选择性更高 。
吡啶-4-基)硫)-2-甲基丙酸,是第二代尿酸转运体 1 Ⅰ期临床研究显示,40 mg RDEA3170 能使健康志
[4]
[1]
(URAT1)抑制剂,能选择性地抑制尿酸重吸收 , 愿者血尿酸平均下降超过 60%,并可持续 36 h ,
收稿日期:2018-05-05; 定用日期:2018-07-16; DOI: 10.13550/j.jxhg.20180321
基金项目:湖北省教育厅重点项目(D20141510);湖北省教育厅项目(B2017053)
作者简介:胡 旭(1985—),男,硕士生。联系人:尹传奇(1966—),男,博士,教授,E-mail:zhyfyin@126.com。